RenovoRx, Inc. (RNXT)

1.33 -0.16 (-10.74%) USD  |  NASDAQ  |  Oct 30, 16:00
1.34 +0.01 (+0.75%) After-Hours: 20:00
More

RenovoRx EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for RNXT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS Diluted (5 Year Growth) Data

View and export this data back to 2024. Start Trial.
Date Value
December 31, 2025 --
Date Value
December 31, 2024 --

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Enanta Pharmaceuticals, Inc. Upgrade
Travere Therapeutics, Inc. Upgrade
REGENXBIO, Inc. Upgrade
Krystal Biotech, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade